Most lately, it's been recognized that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in related parts as classical opioid receptors, it binds to your big range of endogenous opioids. Unlike most opioid receptors, this receptor functions to be a scavenger and will not activate a 2nd messenger program